LAS VEGAS, April 4, 2018 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) has completed the technology transfer for the manufacturing of time-released nanoparticles containing a cannabinoid -based therapeutic for neuropathic pain from the University of Seville. As announced in Q4 of 2017, GB … Read More
The post GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid -Based … appeared first on Dagga Magazine.